Neutralizing human monoclonal antibodies prevent Zika virus infection in macaques
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | MAGNANI, Diogo M. | |
dc.contributor.author | ROGERS, Thomas F. | |
dc.contributor.author | BEUTLER, Nathan | |
dc.contributor.author | RICCIARDI, Michael J. | |
dc.contributor.author | BAILEY, Varian K. | |
dc.contributor.author | GONZALEZ-NIETO, Lucas | |
dc.contributor.author | BRINEY, Bryan | |
dc.contributor.author | SOK, Devin | |
dc.contributor.author | LE, Khoa | |
dc.contributor.author | STRUBEL, Alexander | |
dc.contributor.author | GUTMAN, Martin J. | |
dc.contributor.author | PEDRENO-LOPEZ, Nuria | |
dc.contributor.author | GRUBAUGH, Nathan D. | |
dc.contributor.author | SILVEIRA, Cassia G. T. | |
dc.contributor.author | MAXWELL, Helen S. | |
dc.contributor.author | DOMINGUES, Aline | |
dc.contributor.author | MARTINS, Mauricio A. | |
dc.contributor.author | LEE, David E. | |
dc.contributor.author | OKWUAZI, Erica E. | |
dc.contributor.author | JEAN, Sherrie | |
dc.contributor.author | STROBERT, Elizabeth A. | |
dc.contributor.author | CHAHROUDI, Ann | |
dc.contributor.author | SILVESTRI, Guido | |
dc.contributor.author | VANDERFORD, Thomas H. | |
dc.contributor.author | KALLAS, Esper G. | |
dc.contributor.author | DESROSIERS, Ronald C. | |
dc.contributor.author | BONALDO, Myrna C. | |
dc.contributor.author | WHITEHEAD, Stephen S. | |
dc.contributor.author | BURTON, Dennis R. | |
dc.contributor.author | WATKINS, David I. | |
dc.date.accessioned | 2017-12-12T13:14:23Z | |
dc.date.available | 2017-12-12T13:14:23Z | |
dc.date.issued | 2017 | |
dc.description.abstract | Therapies to prevent maternal Zika virus (ZIKV) infection and its subsequent fetal developmental complications are urgently required. We isolated three potent ZIKV-neutralizing monoclonal antibodies (nmAbs) from the plasma-blasts of a ZIKV-infected patient-SMZAb1, SMZAb2, and SMZAb5-directed against two different domains of the virus. We engineered these nmAbs with Fc LALA mutations that abrogate Fc gamma receptor binding, thus eliminating potential therapy-mediated antibody-dependent enhancement. We administered a cocktail of these three nmAbs to nonhuman primates 1 day before challenge with ZIKV and demonstrated that the nmAbs completely prevented viremia in serum after challenge. Given that numerous antibodies have exceptional safety profiles in humans, the cocktail described here could be rapidly developed to protect uninfected pregnant women and their fetuses. | |
dc.description.index | MEDLINE | |
dc.description.sponsorship | NIH [4P01AI094420-05, P30AI073961, P51 OD011132] | |
dc.description.sponsorship | Wallace H. Coulter Center for Translational Research at the University of Miami | |
dc.description.sponsorship | Miami Clinical and Translational Science Institute (CTSI) | |
dc.description.sponsorship | National Institute of Allergy and Infectious Diseases, NIH | |
dc.description.sponsorship | Defense Advanced Research Projects Agency (DARPA) Autonomous Diagnostics to Enable Prevention and Therapeutics: Prophylactic Options to Environmental and Contagious Threats (ADEPT-PROTECT) program [W31P4Q-13-1-0011] | |
dc.identifier.citation | SCIENCE TRANSLATIONAL MEDICINE, v.9, n.410, article ID eaan8184, 7p, 2017 | |
dc.identifier.doi | 10.1126/scitranslmed.aan8184 | |
dc.identifier.eissn | 1946-6242 | |
dc.identifier.issn | 1946-6234 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/24186 | |
dc.language.iso | eng | |
dc.publisher | AMER ASSOC ADVANCEMENT SCIENCE | |
dc.relation.ispartof | Science Translational Medicine | |
dc.rights | restrictedAccess | |
dc.rights.holder | Copyright AMER ASSOC ADVANCEMENT SCIENCE | |
dc.subject.other | dengue virus | |
dc.subject.other | dependent enhancement | |
dc.subject.other | structural basis | |
dc.subject.other | rhesus-monkeys | |
dc.subject.other | protection | |
dc.subject.other | vaccine | |
dc.subject.other | disease | |
dc.subject.other | binding | |
dc.subject.other | mice | |
dc.subject.wos | Cell Biology | |
dc.subject.wos | Medicine, Research & Experimental | |
dc.title | Neutralizing human monoclonal antibodies prevent Zika virus infection in macaques | |
dc.type | article | |
dc.type.category | original article | |
dc.type.version | publishedVersion | |
dspace.entity.type | Publication | |
hcfmusp.affiliation.country | Estados Unidos | |
hcfmusp.affiliation.countryiso | us | |
hcfmusp.author.external | MAGNANI, Diogo M.:Univ Miami, Dept Pathol, Leonard M Miller Sch Med, Miami, FL 33136 USA | |
hcfmusp.author.external | ROGERS, Thomas F.:Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA | |
hcfmusp.author.external | BEUTLER, Nathan:Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA | |
hcfmusp.author.external | RICCIARDI, Michael J.:Univ Miami, Dept Pathol, Leonard M Miller Sch Med, Miami, FL 33136 USA | |
hcfmusp.author.external | BAILEY, Varian K.:Univ Miami, Dept Pathol, Leonard M Miller Sch Med, Miami, FL 33136 USA | |
hcfmusp.author.external | GONZALEZ-NIETO, Lucas:Univ Miami, Dept Pathol, Leonard M Miller Sch Med, Miami, FL 33136 USA | |
hcfmusp.author.external | BRINEY, Bryan:Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA | |
hcfmusp.author.external | SOK, Devin:Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA | |
hcfmusp.author.external | LE, Khoa:Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA | |
hcfmusp.author.external | STRUBEL, Alexander:Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA | |
hcfmusp.author.external | GUTMAN, Martin J.:Univ Miami, Dept Pathol, Leonard M Miller Sch Med, Miami, FL 33136 USA | |
hcfmusp.author.external | PEDRENO-LOPEZ, Nuria:Univ Miami, Dept Pathol, Leonard M Miller Sch Med, Miami, FL 33136 USA | |
hcfmusp.author.external | GRUBAUGH, Nathan D.:Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA | |
hcfmusp.author.external | MAXWELL, Helen S.:Univ Miami, Dept Pathol, Leonard M Miller Sch Med, Miami, FL 33136 USA | |
hcfmusp.author.external | DOMINGUES, Aline:Univ Miami, Dept Pathol, Leonard M Miller Sch Med, Miami, FL 33136 USA | |
hcfmusp.author.external | MARTINS, Mauricio A.:Univ Miami, Dept Pathol, Leonard M Miller Sch Med, Miami, FL 33136 USA | |
hcfmusp.author.external | LEE, David E.:Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA | |
hcfmusp.author.external | OKWUAZI, Erica E.:Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA | |
hcfmusp.author.external | JEAN, Sherrie:Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA | |
hcfmusp.author.external | STROBERT, Elizabeth A.:Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA | |
hcfmusp.author.external | CHAHROUDI, Ann:Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; Emory Univ, Dept Pediat, Atlanta, GA 30322 USA | |
hcfmusp.author.external | SILVESTRI, Guido:Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA | |
hcfmusp.author.external | VANDERFORD, Thomas H.:Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA | |
hcfmusp.author.external | DESROSIERS, Ronald C.:Univ Miami, Dept Pathol, Leonard M Miller Sch Med, Miami, FL 33136 USA | |
hcfmusp.author.external | BONALDO, Myrna C.:Fiocruz MS, Lab Biol Mol Flavivirus, Inst Oswaldo Cruz, BR-21040360 Rio De Janeiro, Brazil | |
hcfmusp.author.external | WHITEHEAD, Stephen S.:NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA | |
hcfmusp.author.external | BURTON, Dennis R.:Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA | |
hcfmusp.author.external | WATKINS, David I.:Univ Miami, Dept Pathol, Leonard M Miller Sch Med, Miami, FL 33136 USA | |
hcfmusp.citation.scopus | 72 | |
hcfmusp.contributor.author-fmusphc | CASSIA GISELE TERRASSANI SILVEIRA | |
hcfmusp.contributor.author-fmusphc | ESPER GEORGES KALLAS | |
hcfmusp.description.articlenumber | eaan8184 | |
hcfmusp.description.issue | 410 | |
hcfmusp.description.volume | 9 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 28978754 | |
hcfmusp.origem.scopus | 2-s2.0-85030571167 | |
hcfmusp.origem.wos | WOS:000412167400005 | |
hcfmusp.publisher.city | WASHINGTON | |
hcfmusp.publisher.country | USA | |
hcfmusp.relation.reference | Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938 | |
hcfmusp.relation.reference | Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365 | |
hcfmusp.relation.reference | Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816 | |
hcfmusp.relation.reference | Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412 | |
hcfmusp.relation.reference | Brien JD, 2013, CURR PROTOC MICROBIO, V31, DOI 10.1002/9780471729259.MC15D03S31 | |
hcfmusp.relation.reference | de Alwis R, 2014, METHODS MOL BIOL, V1138, P27, DOI 10.1007/978-1-4939-0348-1_3 | |
hcfmusp.relation.reference | Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515 | |
hcfmusp.relation.reference | Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137 | |
hcfmusp.relation.reference | Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020 | |
hcfmusp.relation.reference | Durbin AP, 2001, AM J TROP MED HYG, V65, P405 | |
hcfmusp.relation.reference | Fuss I. J., 2009, CURR PROTOC IMMUNOL | |
hcfmusp.relation.reference | Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3 | |
hcfmusp.relation.reference | HALSTEAD SB, 1979, J INFECT DIS, V140, P527 | |
hcfmusp.relation.reference | Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106 | |
hcfmusp.relation.reference | Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005 | |
hcfmusp.relation.reference | Juckstock J, 2015, PHARMACOLOGY, V95, P209, DOI 10.1159/000381626 | |
hcfmusp.relation.reference | Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07 | |
hcfmusp.relation.reference | Lai CJ, 2007, J VIROL, V81, P12766, DOI 10.1128/JVI.01420-07 | |
hcfmusp.relation.reference | Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952 | |
hcfmusp.relation.reference | Magnani D. M., 2017, MOL THER | |
hcfmusp.relation.reference | Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762 | |
hcfmusp.relation.reference | Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651 | |
hcfmusp.relation.reference | Null D, 1998, PEDIATRICS, V102, P531 | |
hcfmusp.relation.reference | Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113 | |
hcfmusp.relation.reference | Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1 | |
hcfmusp.relation.reference | Robbie GJ, 2013, ANTIMICROB AGENTS CH, V57, P6147, DOI 10.1128/AAC.01285-13 | |
hcfmusp.relation.reference | Rogers T. F., 2017, SCI IMMUNOL, V2 | |
hcfmusp.relation.reference | Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311 | |
hcfmusp.relation.reference | Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564 | |
hcfmusp.relation.reference | Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7 | |
hcfmusp.relation.reference | Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132 | |
hcfmusp.relation.reference | Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10 | |
hcfmusp.relation.reference | Wang TT, 2017, SCIENCE, V355, P395, DOI 10.1126/science.aai8128 | |
hcfmusp.relation.reference | World Health Organization, 2005, 5 M EM COMM INT HLTH | |
hcfmusp.relation.reference | Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020 | |
hcfmusp.scopus.lastupdate | 2024-05-17 | |
relation.isAuthorOfPublication | 7e311325-87a6-42c6-97eb-5fcb36f60e6c | |
relation.isAuthorOfPublication | 28071dc0-9dc3-4896-81cf-c90be6515b24 | |
relation.isAuthorOfPublication.latestForDiscovery | 7e311325-87a6-42c6-97eb-5fcb36f60e6c |
Arquivos
Pacote Original
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- art_MAGNANI_Neutralizing_human_monoclonal_antibodies_prevent_Zika_virus_infection_2017.PDF
- Tamanho:
- 463.1 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)